Filing Flows

Filing Flows › Escalon Medical (ESMC) › Q4 FY26

Escalon Medical (ESMC) Q4 FY26 earnings results (fourth quarter fiscal 2026)

10-K filed Oct 13, 2026

Escalon Medical (ESMC) reported revenue of $3.9M for the fourth quarter fiscal 2026 (Q4 FY26), +50% from a year earlier and +48% from the quarter before. Operating margin was 14.7%, net earnings $1.8M (46.1% of revenue).

Revenue$3.9M
Year over year+50%
Quarter over quarter+48%
Operating margin14.7%
Net earnings$1.8M

Escalon Medical, Q4 FY26: revenue $3.9M (+50% year over year), operating margin 14.7%, net earnings $1.8M, operating cash flow −$251K. The chart follows the revenue to costs, profit and cash.

Q4 FY26AmountQ/QY/Y
Revenue$3.9M+48%+50%
Operating profit$569K——
Net earnings$1.8M-25%—
Operating cash flow−$251K-189%-1694%

What changed

Revenue was $3.9M in Q4 FY26, up 50% year over year and up 48% from the previous quarter. Product was the largest line at 95% of revenue.

Operating profit was $569K, a 14.7% margin (up 29.2 points year over year). Total costs grew 12% against revenue growth of 50%. The fastest-growing cost line was Cost of revenue (+32%). Net earnings were $1.8M. The tax line was a benefit of $1.1M on pre-tax earnings of $642K.

Operating cash flow was −$251K. Non-cash charges added back $3K of depreciation and amortization. Working capital and other items used $2.0M.

Questions

What was Escalon Medical's revenue in the fourth quarter fiscal 2026?

Escalon Medical (ESMC) reported revenue of $3.9M for the fourth quarter fiscal 2026 (Q4 FY26), +50% from a year earlier and +48% from the quarter before.

Was Escalon Medical profitable in the fourth quarter fiscal 2026?

Operating profit was $569K (14.7% of revenue) and net earnings $1.8M.

Open the interactive Sankey →

Source: Escalon Medical 10-K on SEC EDGAR.